For someone whose medical practice has had an impact on patients around the world, Dr. Alan Tick Hirsch was too modest to seek attention for it.
"He didn't tell anybody what he'd done," said his wife, Sue Duval.
Hirsch helped bring to the forefront the importance of preventing peripheral artery disease. At the same time, he worked so that millions of patients would get reimbursed for treatment for an affliction that affects 120 million people worldwide and often results in leg amputations and death.
Hirsch died April 14 at the age of 62. His cause of death has not yet been determined, Duval said.
The first time Dr. Russell Luepker met Hirsch 30 years ago, the two made an immediate connection. Both came from Boston to teach and practice medicine, and both had a keen interest in treating and preventing diseases of the circulatory system — the ones that cause heart attacks, aneurysms and strokes.
Luepker was impressed with Hirsch's enthusiasm for and knowledge of the subject. Luepker was 10 years older, but he said Hirsch knew more about some aspects of the field. "His enthusiasm was infectious," Luepker said. "And it spread to others. It catapulted him to leadership positions in his field."
Hirsch came to the University of Minnesota after graduating from Harvard. Luepker said he was drawn to Hirsch's intensity and knowledge of cardiovascular disease, and so he began mentoring him.
Hirsch studied the effect of exercise on improving blood flow to the limbs in hopes of preventing amputations. The field already had a standard of treatment for people with vascular disease, Luepker said, "the plumbing approach"— surgery to install a stent. There was considerable resistance to try something new, Luepker said.